Jun 2026 (Q2 FY26) — Aug 4, 2026
IPG Photonics Q2 FY26 — Strong Revenue Growth and Strategic Acquisitions Drive Performance
Read the full callIPG Photonics earnings: last reported Tue, 4 Aug 2026, for the quarter ended Jun 2026.
Reported
Each figure keeps its basis and period; nothing is filled in.
| Metric | Value | Change | Basis | Period | Note |
|---|---|---|---|---|---|
| Revenue | 279 | +11.1% YoY | Quarterly, as filed | Quarter to Jun 2026 | Revenue from operations as filed. |
| Operating margin | 1.6 | +1.6 pts YoY | Operating profit / revenue | Quarter to Jun 2026 | For the quarter; a change is in percentage points. |
| Net profit | 5.2 | −20.6% YoY | Quarterly, as filed | Quarter to Jun 2026 | Profit after tax as filed. |
Price
1Y: $83.2 on 14 Oct 2025 → $73.76. High $153.91 (13 Feb 2026), low $70.74 (24 Aug 2026).
Overview
Call summaries
IPG Photonics Q2 FY26 — Strong Revenue Growth and Strategic Acquisitions Drive Performance
Read the full callIPG Photonics Q1 FY26 — Strong Revenue Growth Driven by Battery Manufacturing and Medical
Read the full callEvery analysed call
Financials
Net profit, year on year: −21% (quarter to jun 2026 against jun 2025).
| Line item | Sep 2024 | Dec 2024 | Mar 2025 | Jun 2025 | Sep 2025 | Dec 2025 | Mar 2026 | Jun 2026 |
|---|---|---|---|---|---|---|---|---|
| Sales | 233 | 234 | 228 | 251 | 251 | 274 | 265 | 279 |
| Operating profit | -253 | 14 | 2 | 0 | 8 | 3 | -8 | 5 |
| Operating margin | −108.7% | 6.0% | 0.8% | 0.0% | 3.1% | 1.2% | −2.9% | 1.6% |
| Other income | 11 | 8 | 9 | 8 | 8 | 7 | 9 | 8 |
| Profit before tax | -243 | 22 | 11 | 8 | 16 | 11 | 1 | 13 |
| Tax rate | 3.7% | 64.5% | 64.6% | 20.1% | 52.3% | −25.7% | −55.5% | 58.2% |
| Net profit | -234 | 8 | 4 | 7 | 7 | 13 | 2 | 5 |
| EPS ($ per share) | -5.33 | — | 0.09 | 0.16 | 0.18 | — | 0.04 | 0.12 |
| Line item | Dec 2018 | Dec 2019 | Dec 2020 | Dec 2021 | Dec 2022 | Dec 2023 | Dec 2024 | Dec 2025 |
|---|---|---|---|---|---|---|---|---|
| Equity capital | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Reserves | 1,849 | 2,029 | 2,188 | 2,467 | 2,577 | 2,795 | 2,614 | 2,645 |
| Total liabilities | 368 | 328 | 342 | 423 | 358 | 284 | 265 | 296 |
| Fixed assets | 543 | 601 | 598 | 635 | 581 | 602 | 588 | 638 |
| Investments | 500 | 503 | 515 | 805 | 479 | 663 | 310 | 436 |
| Total assets | 2,574 | 2,730 | 2,936 | 3,171 | 2,743 | 2,699 | 2,289 | 2,424 |
| Line item | Dec 2018 | Dec 2019 | Dec 2020 | Dec 2021 | Dec 2022 | Dec 2023 | Dec 2024 | Dec 2025 |
|---|---|---|---|---|---|---|---|---|
| Cash from operations | 393 | 324 | 285 | 390 | 213 | 296 | 248 | 75 |
| Cash from investing | -563 | -140 | -100 | -416 | 297 | -238 | 209 | -265 |
| Cash from financing | -167 | -37 | -10 | -125 | -515 | -236 | -340 | -54 |
| Net cash flow | -366 | 139 | 196 | -169 | -11 | -184 | 105 | -216 |
| Capital expenditure | -160 | -134 | -88 | -123 | -110 | -110 | -99 | -79 |
| Free cash flow | 233 | 190 | 198 | 267 | 103 | 186 | 149 | -3 |
177 filings between Oct 17, 2025 and Oct 2, 2026.
Purchases
$199.4K
2 purchases by 1 insider
Sales
$78.60M
144 sales by 10 insiders
97% filed under a 10b5-1 plan — scheduled in advance, not decided on the day
| Insider | Bought | Sold | Last filing |
|---|---|---|---|
| IP FIBRE DEVICES LTD | — | $42.25M | Oct 2, 2026 |
| Valentin Gapontsev Trust I | — | $31.91M | Sep 2, 2026 |
| SCHERBAKOV EUGENE A | — | $1.78M | Oct 2, 2026 |
| Mammen Timothy PV | — | $1.20M | May 22, 2026 |
| Lopresti Angelo P | — | $496.1K | Jun 29, 2026 |
| Agnes Tang | — | $322.4K | Jun 22, 2026 |
| Ness Trevor | — | $273.0K | Nov 18, 2025 |
| PEELER JOHN R | $199.4K | — | Aug 26, 2026 |
| Date | Insider | What | Shares | Value |
|---|---|---|---|---|
| Oct 2, 2026 | SCHERBAKOV EUGENE A Director | Sale 10b5-1 plan | 3,048 | $260.0K |
| Oct 2, 2026 | IP FIBRE DEVICES LTD 10% owner | Sale 10b5-1 plan | 9,876 | $843.3K |
| Oct 2, 2026 | IP FIBRE DEVICES LTD 10% owner | Sale 10b5-1 plan | 5,485 | $472.2K |
| Sep 2, 2026 | Valentin Gapontsev Trust I 10% owner | Sale 10b5-1 plan | 4,715 | $359.5K |
| Sep 2, 2026 | Valentin Gapontsev Trust I 10% owner | Sale 10b5-1 plan | 4,591 | $347.3K |
| Sep 1, 2026 | Valentin Gapontsev Trust I 10% owner | Sale 10b5-1 plan | 18,091 | $1.36M |
| Aug 26, 2026 | PEELER JOHN R Director | Purchase | 1,158 | $86.4K |
| Aug 26, 2026 | PEELER JOHN R Director | Purchase | 1,552 | $113.0K |
| Aug 8, 2026 | Bucher Paulus SVP, Global Operations | Tax withheld | 663 | $59.8K |
| Aug 5, 2026 | IP FIBRE DEVICES LTD 10% owner | Sale 10b5-1 plan | 11,912 | $1.14M |
| Aug 5, 2026 | IP FIBRE DEVICES LTD 10% owner | Sale 10b5-1 plan | 550 | $54.3K |
| Aug 5, 2026 | IP FIBRE DEVICES LTD 10% owner | Sale 10b5-1 plan | 4,324 | $422.9K |
| Aug 5, 2026 | IP FIBRE DEVICES LTD 10% owner | Sale 10b5-1 plan | 1,325 | $128.2K |
| Aug 4, 2026 | IP FIBRE DEVICES LTD 10% owner | Sale 10b5-1 plan | 12,202 | $1.16M |
| Jul 31, 2026 | IP FIBRE DEVICES LTD 10% owner | Sale 10b5-1 plan | 300 | $26.6K |
| Jul 31, 2026 | IP FIBRE DEVICES LTD 10% owner | Sale 10b5-1 plan | 506 | $43.6K |
| Jul 31, 2026 | IP FIBRE DEVICES LTD 10% owner | Sale 10b5-1 plan | 200 | $17.5K |
| Jul 31, 2026 | SCHERBAKOV EUGENE A Director | Sale 10b5-1 plan | 783 | $67.1K |
| Jul 31, 2026 | IP FIBRE DEVICES LTD 10% owner | Sale 10b5-1 plan | 25,994 | $2.23M |
| Jul 31, 2026 | SCHERBAKOV EUGENE A Director | Sale 10b5-1 plan | 241 | $21.4K |
| Jul 31, 2026 | SCHERBAKOV EUGENE A Director | Sale 10b5-1 plan | 300 | $26.2K |
| Jul 31, 2026 | SCHERBAKOV EUGENE A Director | Sale 10b5-1 plan | 200 | $17.3K |
| Jul 21, 2026 | Valentin Gapontsev Trust I 10% owner | Sale 10b5-1 plan | 1,000 | $100.1K |
| Jul 21, 2026 | Valentin Gapontsev Trust I 10% owner | Sale 10b5-1 plan | 23,869 | $2.46M |
| Jul 21, 2026 | Valentin Gapontsev Trust I 10% owner | Sale 10b5-1 plan | 24,347 | $2.48M |
| Jul 21, 2026 | Valentin Gapontsev Trust I 10% owner | Sale 10b5-1 plan | 7,100 | $718.5K |
| Jun 29, 2026 | IP FIBRE DEVICES LTD 10% owner | Sale 10b5-1 plan | 2,684 | $282.8K |
| Jun 29, 2026 | IP FIBRE DEVICES LTD 10% owner | Sale 10b5-1 plan | 16,406 | $1.71M |
| Jun 29, 2026 | IP FIBRE DEVICES LTD 10% owner | Sale 10b5-1 plan | 13,304 | $1.37M |
| Jun 29, 2026 | IP FIBRE DEVICES LTD 10% owner | Sale 10b5-1 plan | 11,325 | $1.20M |
| Jun 29, 2026 | IP FIBRE DEVICES LTD 10% owner | Sale 10b5-1 plan | 17,735 | $1.81M |
| Jun 29, 2026 | IP FIBRE DEVICES LTD 10% owner | Sale 10b5-1 plan | 2,405 | $243.4K |
| Jun 29, 2026 | Lopresti Angelo P SVP, Secretary & Gen Counsel | Sale 10b5-1 plan | 1,000 | $110.3K |
| Jun 29, 2026 | IP FIBRE DEVICES LTD 10% owner | Sale 10b5-1 plan | 1,841 | $184.4K |
| Jun 29, 2026 | SCHERBAKOV EUGENE A Director | Sale 10b5-1 plan | 200 | $21.3K |
| Jun 29, 2026 | SCHERBAKOV EUGENE A Director | Sale 10b5-1 plan | 1 | $105 |
| Jun 29, 2026 | SCHERBAKOV EUGENE A Director | Sale 10b5-1 plan | 100 | $10.3K |
| Jun 29, 2026 | SCHERBAKOV EUGENE A Director | Sale 10b5-1 plan | 250 | $25.3K |
| Jun 29, 2026 | SCHERBAKOV EUGENE A Director | Sale 10b5-1 plan | 973 | $97.7K |
| Jun 22, 2026 | Agnes Tang Director | Sale 10b5-1 plan | 775 | $90.9K |
| Jun 22, 2026 | Agnes Tang Director | Sale 10b5-1 plan | 536 | $63.3K |
| Jun 22, 2026 | Agnes Tang Director | Sale 10b5-1 plan | 200 | $23.9K |
| Jun 5, 2026 | Gitin Mark Milton CEO | Tax withheld | 4,641 | $498.3K |
| May 22, 2026 | Mammen Timothy PV SVP, Chief Financial Officer | Sale | 2,712 | $326.4K |
| May 22, 2026 | Mammen Timothy PV SVP, Chief Financial Officer | Sale | 7,263 | $868.7K |
| May 14, 2026 | Desmond Jeanmarie F. Director | Sale | 1,690 | $178.4K |
| May 12, 2026 | KENNEDY KOLLEEN T Director | Award | 2,436 | $0 |
| May 12, 2026 | Dougherty Greg Director | Award | 2,436 | $0 |
| May 12, 2026 | PEELER JOHN R Director | Award | 2,436 | $0 |
| May 12, 2026 | Samartsev Igor SVP, Chief Scientist | Award | 2,436 | $0 |
Source: SEC Form 4 filings. Form 4 reports transactions, not the cap table — absence of filings says nothing about how much an insider owns, and a quiet window is not a signal.
Your own record
Free account. Everything above stays public.
Write why you follow IPG PHOTONICS CORP and the condition you want checked. Inve compares your numeric conditions with available results and management guidance; your own conditions remain yours to review.
Keep reading